^
Association details:
Biomarker:No biomarker
Cancer:Multiple Myeloma
Drug:melphalan (Alkylating agent)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Multiple Myeloma: Induction therapy options include…Melphalan/dexamethasone
Secondary therapy:
dexamethasone